Practical Geriatrics ›› 2023, Vol. 37 ›› Issue (5): 439-443.doi: 10.3969/j.issn.1003-9198.2023.05.003
Previous Articles Next Articles
Received:2023-03-20
Online:2023-05-20
Published:2023-05-22
CLC Number:
| [1] JENKINS T A, NGUYEN J C, POLGLAZE K E, et al. Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis[J]. Nutrients, 2016, 8(1):56. [2] ALBERT P R, BENKELFAT C. The neurobiology of depression--revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies[J]. Philos Trans R Soc Lond B Biol Sci, 2013, 368(1615): 20120535. [3] 彭婉蓉,储珺,郑凯莉,等. 应激感受与老年抑郁:主观经济地位的调节与心理弹性的中介[J]. 中国临床心理学杂志, 2021, 29(5): 1069-1073. [4] HALL I C, REBEC G V, HURLEY L M. Serotonin in the inferior colliculus fluctuates with behavioral state and environmental stimuli[J]. J Exp Biol, 2010, 213(Pt 7): 1009-1017. [5] BECK S G, CHOI K C, LIST T J, et al. Corticosterone alters 5-HT1A receptor-mediated hyperpolarization in area CA1 hippocampal pyramidal neurons[J]. Neuropsychopharmacology, 1996, 14(1): 27-33. [6] KLEIN M O, BATTAGELLO D S, CARDOSO A R, et al. Dopamine: functions, signaling, and association with neurological diseases[J]. Cell Mol Neurobiol, 2019, 39(1): 31-59. [7] CHANG C H, GRACE A A. Amygdala-ventral pallidum pathway decreases dopamine activity after chronic mild stress in rats[J]. Biol Psychiatry, 2014, 76(3): 223-230. [8] PRISCO S, PAGANNONE S, ESPOSITO E. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo[J]. J Pharmacol Exp Ther, 1994, 271(1): 83-90. [9] SAMPSON D, WILLNER P, MUSCAT R. Reversal of antidepressant action by dopamine antagonists in an animal model of depression[J]. Psychopharmacology:Berl, 1991, 104(4): 491-495. [10] DI MATTEO V, DI GIOVANNI G, et al. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies[J]. Prog Brain Res, 2008, 172:7-44. [11] ALBERT P R, VAHID-ANSARI F, LUCKHART C. Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression[J]. Front Behav Neurosci, 2014, 8:199. [12] LLADO-PELFORT L, SANTANA N, GHISI V, et al. 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons[J]. Cereb Cortex, 2012, 22(7): 1487-1497. [13] SIUCIAK J A, BOYLAN C, FRITSCHE M, et al. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration[J]. Brain Res, 1996, 710(1/2): 11-20. [14] KLEIN A B, SANTINI M A, AZNAR S, et al. Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice[J]. Neuroscience, 2010, 169(3): 1007-1016. [15] BALU D T, HOSHAW B A, MALBERG J E, et al. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments[J]. Brain Res, 2008, 1211:37-43. [16] NIBUYA M, MORINOBU S, DUMAN R S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments[J]. J Neurosci, 1995, 15(11): 7539-7547. [17] PIZARRO J M, LUMLEY L A, MEDINA W, et al. Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice[J]. Brain Res, 2004, 1025(1/2): 10-20. [18] CHEN B, DOWLATSHAHI D, MACQUEEN G M, et al. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication[J]. Biol Psychiatry, 2001, 50(4): 260-265. [19] VAIDYA V A, CASTRO M E, PEI Q, et al. Influence of thyroid hormone on 5-HT(1A) and 5-HT(2A) receptor-mediated regulation of hippocampal BDNF mRNA expression[J]. Neuropharmacology, 2001, 40(1): 48-56. [20] MONTANEZ S, MUNN J L, OWENS W A, et al. 5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice[J]. Neurochem Int, 2014, 73:127-131. [21] RICHARDSON-JONES J W, CRAIGE C P, GUIARD B P, et al. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants[J]. Neuron, 2010, 65(1): 40-52. [22] SAMUELS B A, ANACKER C, HU A, et al. 5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response[J]. Nat Neurosci, 2015, 18(11): 1606-1616. [23] NAUTIYAL K M, TRITSCHLER L, AHMARI S E, et al. A lack of serotonin 1b autoreceptors results in decreased anxiety and depression-related behaviors[J]. Neuropsychopharmacology, 2016, 41(12): 2941-2950. [24] MURROUGH J W, HENRY S, HU J, et al. Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder[J]. Psychopharmacology:Berl, 2011, 213(2/3): 547-553. [25] TIGER M, RUCK C, FORSBERG A, et al. Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder[J]. Psychiatry Res, 2014, 223(2): 164-170. [26] HANNON J, HOYER D. Molecular biology of 5-HT receptors[J]. Behav Brain Res, 2008, 195(1): 198-213. [27] ROSEL P, ARRANZ B, URRETAVIZCAYA M, et al. Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims[J]. Neuropsychobiology, 2004, 49(4): 189-195. [28] CARR G V, SCHECHTER L E, LUCKI I. Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats[J]. Psychopharmacology:Berl, 2011, 213(2/3): 499-507. [29] WESOLOWSKA A. Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data[J]. Pharmacol Rep, 2010, 62(4): 564-577. [30] LAPLANTE P, DIORIO J, MEANEY M J. Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor[J]. Brain Res Dev Brain Res, 2002, 139(2): 199-203. [31] CLARKE G, GRENHAM S, SCULLY P, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner[J]. Mol Psychiatry, 2013, 18(6): 666-673. [32] VALLES-COLOMER M, FALONY G, DARZI Y, et al. The neuroactive potential of the human gut microbiota in quality of life and depression[J]. Nat Microbiol, 2019, 4(4): 623-632. [33] CASPI A, SUGDEN K, MOFFITT T E, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene[J]. Science, 2003, 301(5631): 386-389. [34] RISCH N, HERRELL R, LEHNER T, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis[J]. JAMA, 2009, 301(23): 2462-2471. [35] KARG K, BURMEISTER M, SHEDDEN K, et al. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation[J]. Arch Gen Psychiatry, 2011, 68(5): 444-454. [36] PEZAWAS L, MEYER-LINDENBERG A, DRABANT E M, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression[J]. Nat Neurosci, 2005, 8(6): 828-834. [37] ALEXANDER N, KLUCKEN T, KOPPE G, et al. Interaction of the serotonin transporter-linked polymorphic region and environmental adversity: increased amygdala-hypothalamus connectivity as a potential mechanism linking neural and endocrine hyperreactivity[J]. Biol Psychiatry, 2012, 72(1): 49-56. [38] DANNLOWSKI U, OHRMANN P, KONRAD C, et al. Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity[J]. Int J Neuropsychopharmacol, 2009, 12(1): 11-22. [39] FRODL T, KOUTSOULERIS N, BOTTLENDER R, et al. Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression[J]. Mol Psychiatry, 2008, 13(12): 1093-1101. [40] SAVITZ J, LUCKI I, DREVETS W C. 5-HT(1A) receptor function in major depressive disorder[J]. Prog Neurobiol, 2009, 88(1): 17-31. |
| [1] | ZHANG Jian, JIANG Chenguang, YUAN Yonggui. Effects of alexithymia and social support on anhedonia and depressive symptoms in elderly patients with late-life depression [J]. Practical Geriatrics, 2024, 38(10): 997-1001. |
| [2] | TIAN Jin-chang, LYU Jian, XU Yu. Analysis of the characteristics and influencing factors of nutrition in hospitalized patients with late-life depression [J]. Practical Geriatrics, 2023, 37(8): 785-788. |
| [3] | . [J]. Practical Geriatrics, 2023, 37(6): 541-543. |
| [4] | ZHANG Yi, ZHENG Su-zhen, YANG Li-wei, LIN Qiang. Effect of moderate aerobic exercise on the levels of serotonin, norepinephrine and autonomic function in elderly patients with depression [J]. Practical Geriatrics, 2023, 37(6): 595-598. |
| [5] | . [J]. Practical Geriatrics, 2023, 37(5): 435-438. |
| [6] | LU Wei-wei, LIU Bang-zhong, CHEN Jun, WU Yi-ming, ZHU Shi-jie, ZHU Rui. Association analysis with stratification between depression and adverse childhood experiences in middle-aged and elderly Chinese [J]. Practical Geriatrics, 2023, 37(3): 251-255. |
| [7] | LIU Xiao-Wei, YANG Q-ing, ZHU Pei-Jun, WANG Jin-Liang. Study on the effects of duloxetine and fluxetine on lateonset patients with depression [J]. Practical Geriatrics, 2010, 24(2): 162-164. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
